COVID vaccine production from South Africa's Aspen Pharmacare to end due to low demand - Fox News

Category: Covid
Original source: Fox News
Read time: < 2 minutes
Sentiment bias: Positive
Sentiment Score: 0.85207
Published: Aug 11th, 2022
COVID vaccine production from South Africa's Aspen Pharmacare to end due to low demand - Fox News

Quick Read

The bulk of the company's COVID-19 production lines had been meant to produce Aspenovax for Africa.
However, its existing Aspenovax production lines are currently sitting idle.
Without Aspenovax orders, Aspen would be forced to convert production lines to manufacture anaesthetics, Nicolaou said.
Aspen has had no orders for its Aspenovax vaccine and has not received orders from Johnson & Johnson beyond August.
Without new orders, Aspen would have to shut down all of its 450 million-dose annual production capacity, he said.

COVID vaccine production from South Africa's Aspen Pharmacare to end due to low demand - Fox News

NEW You can now listen to Fox News articles! South Africa's Aspen Pharmacare will stop making COVID-19 vaccines from the end of this month due to a lack of orders, a senior executive said, further undermining Africa's already meager capacity to produce doses. Aspen currently produces vaccines for Johnson & Johnson. In March, it struck a deal to produce, price and sell its own-brand version of the shot for African markets. That deal was considered a game-changer for a continent frustrated by sluggish Western handouts. But while only a fifth of adults in Africa are fully vaccinated, according to the African Centres for Disease Control and Prevention, demand for shots have failed to materialize. Aspen has had no orders for its Aspenovax vaccine and has not received orders from Johnson & Johnson beyond August. JOHNSON & JOHNSON COVID VACCINE LINKED TO DEATH IN SOUTH AFRICA, HEALTH REGULATOR REPORTS J&J did not respond to an email seeking comment. "The thing here is that we don't know if we will get further orders from J&J. But we are finishing off production of what we've got," Stavros Nicolaou, group senior executive at Aspen, told Reuters. Without new orders, Aspen would have to shut down all of its 450 million-dose annual production capacity, he said. Aspen could get some indication from J&J by September as to whether any new orders are in the pipeline, Nicolaou said. But he cautioned that those might not be enough. The bulk of the company's COVID-19 production lines had been meant to produce Aspenovax for Africa. Its initial plans aimed to boost annual capacity to 700 million doses by February and a further expansion to one billion doses to meet expected demand. However, its existing Aspenovax production lines are currently sitting idle. Without Aspenovax orders, Aspen would be forced to convert production lines to manufacture anaesthetics, Nicolaou said. "Then Africa loses its COVID vaccine capacity, the only one really that exists on the continent," he said. "Of course, we cannot continue with vacant lines indefinitely. And we would have to get an order imminently."
The Original Article can be found on Fox News

Recent Covid Articles

Minnesota fall 2022 COVID hospitalization and death predictions

The Centers for Disease Control and Prevention’s new COVID-19 Forecast Hub shows hospitalization and death predictions for Minnesota heading into the fall. The CDC’s forecast comp …

Read more here
Minnesota fall 2022 COVID hospitalization and death predictions
What long COVID looks like in kids

(NEXSTAR) – While it’s not clear exactly how many children suffer from long COVID, doctors who work with children are seeing some of them continue to struggle weeks or months after …

Read more here
What long COVID looks like in kids
COVID-19 boosters for Omicron variant available locally, in select locations

COVID-19 boosters targeting the BA.4 and BA.5 strains are now available across the Central Coast, but supply is limited. If you try to schedule a COVID-19 booster with CVS for exa …

Read more here
COVID-19 boosters for Omicron variant available locally, in select locations
News Scan for Sep 07, 2022

Vaccinated medical conference attendees had low rates of COVID-19 Today JAMA Network Open published a study showing a 1.8% COVID-19 infection rate among in-person attendees at a F …

Read more here
News Scan for Sep 07, 2022
Board debates business incentives, COVID

The late Betty Lynn was known to millions of “The Andy Griffith Show” fans as the long-suffering, sweet-hearted girlfriend of Deputy Barney Fife. Over the decades since the show l …

Read more here
Board debates business incentives, COVID
Latest News
Help & How To's
Around the Web